SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Following Protocols Can Reduce Medication Errors For Heart, Stroke Patients, Study in Circulation: Journal of the American Heart Association
March 23, 2010
 · 
3 min read
Lone Star Bio
New Bone-Hard Biomaterial for Surgical Screws, Fraunhofer Institute for Biomedical Technology Engineering IBMT Study
March 23, 2010
 · 
1 min read
Lone Star Bio
Blacks Less Likely Than Whites, Hispanics To Get Evidence-Based Stroke Care, Study in Circulation: Journal of the American Heart Association
March 23, 2010
 · 
4 min read
Lone Star Bio
New Chemotherapy Combination Shows Promise in Endometrial Cancer, University of Texas MD Anderson Cancer Center Researchers Find
March 19, 2010
 · 
1 min read
Lone Star Bio
New Attack On Cancer Forces Cells To Grow Old And Die, University of Texas MD Anderson Cancer Center Study
March 18, 2010
 · 
1 min read
Lone Star Bio
Hint of Chemoprevention Potential for Lynch Syndrome, M. D. Anderson Cancer Center Study
March 17, 2010
 · 
1 min read
Lone Star Bio
Spinal Restoration, Inc. Initiates Patient Enrollment for Phase III Study of Company’s Biostat(R) System
March 16, 2010
 · 
1 min read
Lone Star Bio
Disease Cause Is Pinpointed With Genome, Baylor College of Medicine Study
March 11, 2010
 · 
1 min read
Lone Star Bio
New Strategy Develops Two Prototype Drugs Against Cancer, Retinal Diseases, University of Texas MD Anderson Cancer Center Study
March 8, 2010
 · 
1 min read
Lone Star Bio
Most Early-Stage Breast Cancer Patients May Not Need Radiation After Mastectomy, University of Texas MD Anderson Cancer Center Study
March 8, 2010
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Axxess 2025 AGILE Conference to be held May 5-7 in Dallas
July 18, 2024
 · 
2 min read
Press Releases
Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives
July 17, 2024
 · 
7 min read
News
MangoRx Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via Surescripts
July 16, 2024
 · 
9 min read
Business
CNS Pharmaceuticals to Participate in the Virtual Investor Closing Bell Series
July 16, 2024
 · 
1 min read
Drug Development
Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis (ALS)
July 16, 2024
 · 
4 min read
Press Releases
Lexicon Pharmaceuticals Receives December 20, 2024 PDUFA Goal Date for Sotagliflozin Type 1 Diabetes NDA Resubmission
July 16, 2024
 · 
3 min read
Press Releases
FibroBiologics to Present at JonesTrading Healthcare Summit 2024
July 15, 2024
 · 
1 min read
Press Releases
New Published Data Highlights Potential Cost-Savings of INPEFA® (sotagliflozin) for Heart Failure
July 15, 2024
 · 
11 min read
Press Releases
Autonomix Enters into Definitive Agreement to License Intellectual Property for FDA-Cleared Ablation Technology from RF Innovations, Inc.
July 15, 2024
 · 
4 min read
Press Releases
Modicus Prime Raises $3.5M to prevent Drug Product Quality failures during Commercial Production
July 15, 2024
 · 
4 min read
Load More